193 related articles for article (PubMed ID: 19252273)
1. Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
Shimohama S
Biol Pharm Bull; 2009 Mar; 32(3):332-6. PubMed ID: 19252273
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity.
Shimohama S; Kihara T
Biol Psychiatry; 2001 Feb; 49(3):233-9. PubMed ID: 11230874
[TBL] [Abstract][Full Text] [Related]
3. Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway.
Ren Z; Yang M; Guan Z; Yu W
Curr Alzheimer Res; 2019; 16(1):39-48. PubMed ID: 30345917
[TBL] [Abstract][Full Text] [Related]
4. Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity.
Kihara T; Sawada H; Nakamizo T; Kanki R; Yamashita H; Maelicke A; Shimohama S
Biochem Biophys Res Commun; 2004 Dec; 325(3):976-82. PubMed ID: 15541385
[TBL] [Abstract][Full Text] [Related]
5. α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease.
Kawamata J; Suzuki S; Shimohama S
Curr Drug Targets; 2012 May; 13(5):623-30. PubMed ID: 22300030
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.
Kawamata J; Suzuki S; Shimohama S
Ther Adv Chronic Dis; 2011 May; 2(3):197-208. PubMed ID: 23251750
[TBL] [Abstract][Full Text] [Related]
7. alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity.
Kihara T; Shimohama S; Sawada H; Honda K; Nakamizo T; Shibasaki H; Kume T; Akaike A
J Biol Chem; 2001 Apr; 276(17):13541-6. PubMed ID: 11278378
[TBL] [Abstract][Full Text] [Related]
8. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.
Kawamata J; Shimohama S
J Alzheimers Dis; 2011; 24 Suppl 2():95-109. PubMed ID: 21403387
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection.
Akaike A; Takada-Takatori Y; Kume T; Izumi Y
J Mol Neurosci; 2010 Jan; 40(1-2):211-6. PubMed ID: 19714494
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of nicotinic acetylcholine receptors protects motor neurons.
Nakamizo T; Kawamata J; Yamashita H; Kanki R; Kihara T; Sawada H; Akaike A; Shimohama S
Biochem Biophys Res Commun; 2005 May; 330(4):1285-9. PubMed ID: 15823582
[TBL] [Abstract][Full Text] [Related]
11. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Arias E; Gallego-Sandín S; Villarroya M; García AG; López MG
J Pharmacol Exp Ther; 2005 Dec; 315(3):1346-53. PubMed ID: 16144975
[TBL] [Abstract][Full Text] [Related]
12. Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid.
Shaw S; Bencherif M; Marrero MB
J Biol Chem; 2002 Nov; 277(47):44920-4. PubMed ID: 12244045
[TBL] [Abstract][Full Text] [Related]
13. Involvement of α7 nAChR signaling cascade in epigallocatechin gallate suppression of β-amyloid-induced apoptotic cortical neuronal insults.
Zhang X; Wu M; Lu F; Luo N; He ZP; Yang H
Mol Neurobiol; 2014 Feb; 49(1):66-77. PubMed ID: 23807728
[TBL] [Abstract][Full Text] [Related]
14. 3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats.
Suzuki S; Kawamata J; Matsushita T; Matsumura A; Hisahara S; Takata K; Kitamura Y; Kem W; Shimohama S
J Neurosci Res; 2013 Mar; 91(3):462-71. PubMed ID: 23239187
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.
Kihara T; Shimohama S; Sawada H; Kimura J; Kume T; Kochiyama H; Maeda T; Akaike A
Ann Neurol; 1997 Aug; 42(2):159-63. PubMed ID: 9266724
[TBL] [Abstract][Full Text] [Related]
16. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
Jonnala RR; Buccafusco JJ
J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
[TBL] [Abstract][Full Text] [Related]
18. α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling.
Yu W; Mechawar N; Krantic S; Quirion R
J Neurochem; 2011 Nov; 119(4):848-58. PubMed ID: 21884524
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors.
Shen H; Kihara T; Hongo H; Wu X; Kem WR; Shimohama S; Akaike A; Niidome T; Sugimoto H
Br J Pharmacol; 2010 Sep; 161(1):127-39. PubMed ID: 20718745
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
